Close Menu

NEW YORK – The US Food and Drug Administration announced late Wednesday that it has authorized the first antibody assay intended for use at the point of care to detect previous SARS-CoV-2 infection. The Assure COVID-19 IgG/IgM Rapid Test Device, which is manufactured by Hangzhou, China-based Assure Tech, is for use on finger-stick blood samples.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.